Karen Guo

Director of China Patents at Novo Nordisk (China) Pharmaceutical Co., Ltd.

Analyzed institutional modifications of pharmaceutical patent protection from the perspective of medical reform objectives.

Speaking History (1 events)

3rd Berkeley-Tsinghua Annual Conference

June 15-16, 2019·Beijing